These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 3210310

  • 21. [Clinical evaluation of imipenem/cilastatin sodium and fosfomycin as second-line combination chemotherapy in severe infections associated with hematologic disorders].
    Tsuda S, Kuzuyama Y, Nakai H, Seriu T, Takashima T, Tanaka S, Horiike S, Taniwaki M, Misawa S, Kashima K.
    Jpn J Antibiot; 1993 Feb; 46(2):171-83. PubMed ID: 8331778
    [Abstract] [Full Text] [Related]

  • 22. [Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in neonates and premature infants].
    Toyonaga Y, Sugita M, Hori M, Joh K.
    Jpn J Antibiot; 1988 Nov; 41(11):1671-91. PubMed ID: 3210301
    [Abstract] [Full Text] [Related]

  • 23. [Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Chimura T, Banzai M, Yamazaki K, Miyata R, Yokoyama Y, Matsuo M, Oda T, Kihara K, Kanasugi H, Takahashi H.
    Jpn J Antibiot; 1991 Dec; 44(12):1351-8. PubMed ID: 1798069
    [Abstract] [Full Text] [Related]

  • 24. [Laboratory and clinical studies on imipenem/cilastatin sodium plus amikacin sulfate in patients with severe infections complicating hematological disorders].
    Hotta T, Morishima Y, Saito H, Kodera Y, Hirabayashi N, Tanaka M, Mizuno H, Suzuki H, Kato Y, Morishita Y.
    Jpn J Antibiot; 1991 May; 44(5):515-28. PubMed ID: 1880931
    [Abstract] [Full Text] [Related]

  • 25. [Clinical evaluation of imipenem/cilastatin sodium as a second line regimen in severe infections associated with hematologic disorders].
    Tsuda S, Nakai H, Murakami T, Seryu S, Takashima T, Tanaka S, Nakagawa H, Nishigaki H, Okuda T, Nishida K.
    Jpn J Antibiot; 1991 Aug; 44(8):886-98. PubMed ID: 1920814
    [Abstract] [Full Text] [Related]

  • 26. [Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders].
    Sawae Y, Niho Y, Okamura T, Gondo H, Kozuru M, Uike N, Muta K, Goto T, Suehiro Y, Kumakawa M, Nishimura J, Yufu Y, Ishikura H, Yamashita S, Hisano S, Morioka E, Nakajima H, Shibuya T, Yamasaki K, Harada N, Asayama R, Hayashi S, Akashi K, Suematsu E, Kawasaki C.
    Jpn J Antibiot; 1996 Dec; 49(12):1049-61. PubMed ID: 9032592
    [Abstract] [Full Text] [Related]

  • 27. [A comparative study of imipenem/cilastatin sodium BID vs QID in the treatment of infections associated with hematopoietic disorders].
    Sawae Y, Niho Y, Okamura T, Murakawa M, Teshima T, Fujisaki T, Ikeda K, Kozuru M, Uike N, Katsuno M.
    Jpn J Antibiot; 1994 Oct; 47(10):1318-28. PubMed ID: 7807693
    [Abstract] [Full Text] [Related]

  • 28. [Clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Chimura T, Banzai M, Nara N, Kawachiya S, Ogawa T, Miyata R, Yamazaki K, Aoyama S, Matsuo M, Yokoyama Y.
    Jpn J Antibiot; 1992 Aug; 45(8):1029-38. PubMed ID: 1433892
    [Abstract] [Full Text] [Related]

  • 29. [Clinical study of imipenem/cilastatin sodium in serious infections in critical care medical center].
    Sakata I, Maruyama J, Takahashi H, Kitagishi H, Nakaji M, Yoshinobu H, Mantani Y, Maruyama K, Iwaki H, Matsushima T.
    Jpn J Antibiot; 1993 May; 46(5):397-403. PubMed ID: 8326679
    [Abstract] [Full Text] [Related]

  • 30. Imipenem/cilastatin as secondary therapy for bacterial infections.
    Kono K, Onuki K, Tohara S, Takeda S.
    Clin Ther; 1991 May; 13(4):448-56. PubMed ID: 1933995
    [Abstract] [Full Text] [Related]

  • 31. [Clinical evaluation of imipenem/cilastatin sodium in infectious complications of hematological malignancies. Tohkai Research Group on Infections in Hematological Disorders].
    Naito K, Kobayashi M, Okumura M, Ikeda Y, Mitomo Y, Oguri T, Tanaka M, Ohara K, Kodera Y, Ohno R.
    Jpn J Antibiot; 1990 Aug; 43(8):1371-80. PubMed ID: 2283705
    [Abstract] [Full Text] [Related]

  • 32. [Clinical evaluation of imipenem/cilastatin sodium in the internal medicine].
    Fukuhara H, Kusano N, Nakamura H, Kaneshima H, Irabu Y, Shimozi K, Kitukawa K, Shigeno Y, Saito A, Kakazu T.
    Jpn J Antibiot; 1991 Aug; 44(8):877-85. PubMed ID: 1920813
    [Abstract] [Full Text] [Related]

  • 33. [Therapeutic effects of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
    Tatsumi N, Nin T, Sannomiya Y, Kageyama T, Ohyabu H, Akasaka K, Nasu K, Yonezawa T, Tominaga N, Kitani T.
    Jpn J Antibiot; 1989 May; 42(5):1065-76. PubMed ID: 2664253
    [Abstract] [Full Text] [Related]

  • 34. [Clinical evaluation of imipenem/cilastatin sodium against infections in compromised children (malignancy, hematological disease, collagen disease)].
    Nakano T, Itoh M, Sakurai M.
    Jpn J Antibiot; 1992 Aug; 45(8):1016-22. PubMed ID: 1433890
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Our experience with the use of tienam in cases of puerperal infection (preliminary report)].
    Pranchev N, Katranushkova N, Nalbanski B, Katsarova M.
    Akush Ginekol (Sofiia); 1988 Aug; 27(3):86-9. PubMed ID: 3177797
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Postpartum endometritis: efficacy and tolerability of two antibiotic regimens.
    Gonik B.
    Clin Ther; 1992 Aug; 14(1):83-9. PubMed ID: 1576630
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Clinical evaluation of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders].
    Tsukada T, Katayama N, Kageyama S, Nishikawa M, Kobayashi T, Deguchi K, Shirakawa S, Minami N.
    Jpn J Antibiot; 1990 Dec; 43(12):2087-93. PubMed ID: 2086823
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.